| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V0A1 DDX31 ATRX ABCA12 ABCA13 SMCHD1 MSH2 SMC5 KIF20B DNAH14 DNAH1 DNAL4 DNAH12 ATP11B HFM1 HSPA1A HSPA1B DNAH8 | 6.39e-07 | 614 | 147 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.73e-06 | 28 | 147 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX31 ATRX ABCA12 ABCA13 SMCHD1 MSH2 SMC5 KIF20B DNAH12 ATP11B HFM1 HSPA1A HSPA1B DNAH8 | 4.92e-06 | 441 | 147 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 7.96e-06 | 18 | 147 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.28e-05 | 70 | 147 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.54e-04 | 37 | 147 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | denatured protein binding | 1.61e-04 | 3 | 147 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.41e-04 | 118 | 147 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 5.31e-04 | 5 | 147 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX31 ATRX ABCA12 ABCA13 SMCHD1 BMS1 MSH2 SMC5 KIF20B DNAH12 ATP11B HFM1 HSPA1A HSPA1B DNAH8 | 6.07e-04 | 775 | 147 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | ATPase inhibitor activity | 7.92e-04 | 6 | 147 | 2 | GO:0042030 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 7.92e-04 | 6 | 147 | 2 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 7.92e-04 | 6 | 147 | 2 | GO:0055131 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DDX31 ATRX ABCA12 ABCA13 SMCHD1 BMS1 MSH2 SMC5 KIF20B DNAH12 ATP11B HFM1 HSPA1A HSPA1B DNAH8 | 1.35e-03 | 839 | 147 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DDX31 ATRX ABCA12 ABCA13 SMCHD1 BMS1 MSH2 SMC5 KIF20B DNAH12 ATP11B HFM1 HSPA1A HSPA1B DNAH8 | 1.37e-03 | 840 | 147 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DDX31 ATRX ABCA12 ABCA13 SMCHD1 BMS1 MSH2 SMC5 KIF20B DNAH12 ATP11B HFM1 HSPA1A HSPA1B DNAH8 | 1.37e-03 | 840 | 147 | 15 | GO:0016818 |
| GeneOntologyBiologicalProcess | regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 4.10e-06 | 16 | 146 | 4 | GO:0070424 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | RSPH4A COPG1 IFT74 ASH1L KIF20B WDPCP DNAH14 DNAH1 FSIP2 DNAL4 DNAH12 CFAP57 DNAH8 | 5.01e-05 | 493 | 146 | 13 | GO:0007018 |
| GeneOntologyBiologicalProcess | organelle assembly | ATXN2L MOSPD2 PDCD6IP TAPT1 RSPH4A IFT74 LDAF1 FASTKD2 OCRL RILPL1 WDPCP DNAH1 FSIP2 RAB3GAP2 PRICKLE2 CFAP57 HSPA1A HSPA1B DNAH8 KNL1 PCNT | 5.24e-05 | 1138 | 146 | 21 | GO:0070925 |
| GeneOntologyBiologicalProcess | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 5.72e-05 | 30 | 146 | 4 | GO:0035872 | |
| GeneOntologyBiologicalProcess | microtubule-based process | SPATA7 PDCD6IP RSPH4A ATRX COPG1 IFT74 ASH1L KIF20B WDPCP DNAH14 DNAH1 FSIP2 DNAL4 DNAH12 CFAP57 MARK2 HSPA1A HSPA1B DNAH8 PCNT | 5.77e-05 | 1058 | 146 | 20 | GO:0007017 |
| GeneOntologyBiologicalProcess | negative regulation of inclusion body assembly | 7.29e-05 | 12 | 146 | 3 | GO:0090084 | |
| GeneOntologyBiologicalProcess | chromosome organization | PDCD6IP EID3 ATRX SMCHD1 MSH2 TEX15 SMC5 ESCO1 YLPM1 HFM1 HSPA1A HSPA1B STAG3 TOP1 KNL1 | 1.09e-04 | 686 | 146 | 15 | GO:0051276 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 1.28e-04 | 210 | 146 | 8 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 1.51e-04 | 215 | 146 | 8 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 1.51e-04 | 215 | 146 | 8 | GO:0001539 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular transport | 1.57e-04 | 162 | 146 | 7 | GO:0032388 | |
| GeneOntologyCellularComponent | cilium | SPATA7 TAPT1 IMPG1 RSPH4A IFT74 OCRL RILPL1 WDPCP DNAH14 DNAH1 FSIP2 DNAL4 DNAH12 SLC24A4 CATSPERB CFAP57 AGBL2 DNAH8 PMFBP1 VDAC2 PCNT | 1.17e-06 | 898 | 146 | 21 | GO:0005929 |
| GeneOntologyCellularComponent | 9+2 motile cilium | RSPH4A DNAH14 DNAH1 FSIP2 DNAH12 CATSPERB CFAP57 DNAH8 PMFBP1 VDAC2 | 6.94e-06 | 238 | 146 | 10 | GO:0097729 |
| GeneOntologyCellularComponent | motile cilium | RSPH4A IFT74 DNAH14 DNAH1 FSIP2 DNAH12 CATSPERB CFAP57 DNAH8 PMFBP1 VDAC2 PCNT | 7.67e-06 | 355 | 146 | 12 | GO:0031514 |
| GeneOntologyCellularComponent | dynein complex | 3.73e-05 | 54 | 146 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | interchromatin granule | 4.78e-04 | 5 | 146 | 2 | GO:0035061 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 6.86e-04 | 25 | 146 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | sperm flagellum | 7.79e-04 | 214 | 146 | 7 | GO:0036126 | |
| GeneOntologyCellularComponent | microtubule associated complex | 9.49e-04 | 161 | 146 | 6 | GO:0005875 | |
| HumanPheno | Irregularly shaped sperm tail | 2.16e-05 | 15 | 60 | 4 | HP:0033393 | |
| HumanPheno | Asymmetry of the ears | 3.03e-05 | 6 | 60 | 3 | HP:0010722 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.11e-06 | 14 | 143 | 4 | IPR024317 | |
| Domain | AAA_8 | 3.11e-06 | 14 | 143 | 4 | PF12780 | |
| Domain | DHC_fam | 4.21e-06 | 15 | 143 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 4.21e-06 | 15 | 143 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.21e-06 | 15 | 143 | 4 | IPR004273 | |
| Domain | FNIP_N_dom | 5.82e-05 | 2 | 143 | 2 | IPR028084 | |
| Domain | FNIP_mid_dom | 5.82e-05 | 2 | 143 | 2 | IPR028085 | |
| Domain | FNIP_C_dom | 5.82e-05 | 2 | 143 | 2 | IPR028086 | |
| Domain | FNIP_C | 5.82e-05 | 2 | 143 | 2 | PF14638 | |
| Domain | FNIP_M | 5.82e-05 | 2 | 143 | 2 | PF14637 | |
| Domain | FNIP_N | 5.82e-05 | 2 | 143 | 2 | PF14636 | |
| Domain | FNIP_fam | 5.82e-05 | 2 | 143 | 2 | IPR026156 | |
| Domain | Dynein_HC_stalk | 1.50e-04 | 14 | 143 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.50e-04 | 14 | 143 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.50e-04 | 14 | 143 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.50e-04 | 14 | 143 | 3 | IPR011704 | |
| Domain | MT | 1.50e-04 | 14 | 143 | 3 | PF12777 | |
| Domain | AAA_5 | 1.50e-04 | 14 | 143 | 3 | PF07728 | |
| Domain | RNA_pol_Rpb1_2 | 1.74e-04 | 3 | 143 | 2 | PF00623 | |
| Domain | RNA_pol_asu | 1.74e-04 | 3 | 143 | 2 | IPR000722 | |
| Domain | RNA_pol_N | 1.74e-04 | 3 | 143 | 2 | IPR006592 | |
| Domain | RNA_pol_Rpb1_1 | 1.74e-04 | 3 | 143 | 2 | PF04997 | |
| Domain | RNA_pol_Rpb1_5 | 1.74e-04 | 3 | 143 | 2 | PF04998 | |
| Domain | RNA_pol_Rpb1_3 | 1.74e-04 | 3 | 143 | 2 | PF04983 | |
| Domain | RNA_pol_Rpb1_4 | 1.74e-04 | 3 | 143 | 2 | PF05000 | |
| Domain | RPOLA_N | 1.74e-04 | 3 | 143 | 2 | SM00663 | |
| Domain | RNA_pol_Rpb1_4 | 1.74e-04 | 3 | 143 | 2 | IPR007083 | |
| Domain | RNA_pol_Rpb1_5 | 1.74e-04 | 3 | 143 | 2 | IPR007081 | |
| Domain | RNA_pol_Rpb1_1 | 1.74e-04 | 3 | 143 | 2 | IPR007080 | |
| Domain | RNA_pol_Rpb1_3 | 1.74e-04 | 3 | 143 | 2 | IPR007066 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | AARS1 DENND4A ATP6V0A1 POLR1A PDCD6IP ATRX COPG1 MAT2B RPN2 PUF60 CPSF6 SMCHD1 POLR2A BMS1 SRP14 BIRC3 NOL10 FASTKD2 MSH2 GFPT1 RAB3GAP2 SUPT16H DLST FGD5 EIF3I SNRPA HSPA1A TOP1 VDAC2 | 2.93e-12 | 1425 | 150 | 29 | 30948266 |
| Pubmed | ATXN2L AARS1 DDX31 POLR1A PDCD6IP COPG1 RPN2 PUF60 SMCHD1 POLR2A BMS1 NOL10 MSH2 GFPT1 YLPM1 EIF3I TOP1 PCNT | 5.33e-10 | 653 | 150 | 18 | 22586326 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PIGN ATXN2L PDCD6IP UACA DSG3 RPN2 PUF60 CPSF6 SMCHD1 BMS1 NOL10 MSH2 TRIM27 KIF20B GFPT1 SUPT16H DLST MARK2 SPATS2 EIF3I SNRPA HSPA1B TOP1 VDAC2 | 9.93e-10 | 1257 | 150 | 24 | 36526897 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ATXN2L ZNF148 ATRX PUF60 CPSF6 SMCHD1 POLR2A SRP14 NOL10 SMC5 KIF20B LENG8 YLPM1 SUPT16H EIF3I SNRPA HSPA1A ZNF281 TOP1 VDAC2 KNL1 | 1.02e-09 | 954 | 150 | 21 | 36373674 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ATXN2L AARS1 ZNF148 ATRX PUF60 CPSF6 SMCHD1 POLR2A OCRL GFPT1 LENG8 YLPM1 EIF3I HSPA1A ZNF281 TOP1 GOLGB1 VDAC2 KNL1 PCNT | 4.22e-09 | 934 | 150 | 20 | 33916271 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | ATXN2L ZNF148 CPSF6 SMCHD1 POLR2A SRP14 MSH2 LENG8 YLPM1 SUPT16H ZNF281 TOP1 | 3.35e-08 | 341 | 150 | 12 | 32971831 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DDX31 PDCD6IP RPN2 CPSF6 SMCHD1 POLR2A BMS1 SRP14 NOL10 MSH2 KIF20B LENG8 S100A11 YLPM1 SUPT16H HSPA1B TOP1 VDAC2 KNL1 | 5.89e-08 | 989 | 150 | 19 | 36424410 |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 24667831 | ||
| Pubmed | AARS1 POLR1A PDCD6IP ATRX PUF60 SMCHD1 POLR2A SRP14 MSH2 SMC5 GFPT1 S100A11 GTF2F1 YLPM1 SUPT16H EIF3I SNRPA TOP1 VDAC2 | 8.68e-08 | 1014 | 150 | 19 | 32416067 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | AARS1 POLR1A PDCD6IP RASA2 COPG1 SMCHD1 POLR2A BMS1 SRP14 NOL10 FASTKD2 MSH2 OCRL KIF20B GFPT1 SUPT16H DLST EIF3I SNRPA ZNF281 TOP1 VDAC2 | 9.14e-08 | 1353 | 150 | 22 | 29467282 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | ATXN2L POLR1A FRMPD4 UACA COPG1 PUF60 CPSF6 TPRN SRP14 NOL10 GFPT1 SUPT16H MARK2 SNRPA HSPA1A HSPA1B TOP1 VDAC2 | 1.63e-07 | 949 | 150 | 18 | 36574265 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ATXN2L DDX31 POLR1A SMCHD1 BMS1 NOL10 MSH2 SMC5 KIF20B SUPT16H MIOS DLST MARK2 SPATS2 EIF3I TOP1 | 2.06e-07 | 759 | 150 | 16 | 35915203 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DDX31 ZNF148 POLR1A PDCD6IP COPG1 RPN2 PUF60 CPSF6 SMCHD1 BMS1 SRP14 NOL10 FASTKD2 MSH2 TAMM41 SUPT16H EIF3I SNRPA HSPA1A TOP1 VDAC2 | 2.58e-07 | 1318 | 150 | 21 | 30463901 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | PDCD6IP ATRX COPG1 PUF60 CPSF6 SMCHD1 MSH2 YLPM1 MARK2 SNRPA TOP1 GOLGB1 KNL1 PCNT | 2.58e-07 | 582 | 150 | 14 | 20467437 |
| Pubmed | Ubiquitin-Activated Interaction Traps (UBAITs) identify E3 ligase binding partners. | 2.93e-07 | 62 | 150 | 6 | 26508657 | |
| Pubmed | ATXN2L AARS1 ZNF148 MAT2B PUF60 CPSF6 SMCHD1 SRP14 MSH2 LENG8 S100A11 GTF2F1 RAB3GAP2 SNRPA HSPA1B ZNF281 TOP1 KNL1 ZNF292 | 3.15e-07 | 1103 | 150 | 19 | 34189442 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | ATXN2L AARS1 PDCD6IP COPG1 RPN2 PUF60 CPSF6 GFPT1 SUPT16H DLST EIF3I SNRPA TOP1 VDAC2 | 4.27e-07 | 607 | 150 | 14 | 39147351 |
| Pubmed | ATP6V0A1 MOSPD2 DDX31 ZNF148 TAPT1 ATRX UACA MAT2B RPN2 BMS1 SRP14 FASTKD2 TRIM27 RAB3GAP2 SUPT16H ROBO1 DLST MARK2 HSPA1A HSPA1B GOLGB1 PCNT | 4.56e-07 | 1487 | 150 | 22 | 33957083 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | ATXN2L DDX31 PUF60 CPSF6 POLR2A BMS1 SRP14 NOL10 FASTKD2 GTF2F1 YLPM1 SUPT16H SNRPA HSPA1A HSPA1B TOP1 | 4.65e-07 | 807 | 150 | 16 | 22681889 |
| Pubmed | ATXN2L AARS1 PDCD6IP COPG1 RPN2 PUF60 CPSF6 GFPT1 MIOS HSPA1A HSPA1B TOP1 | 6.72e-07 | 451 | 150 | 12 | 36168627 | |
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 27137183 | ||
| Pubmed | Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. | 7.81e-07 | 5 | 150 | 3 | 16906134 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | AARS1 PDCD6IP COPG1 MAT2B RPN2 PUF60 CPSF6 SMCHD1 POLR2A SRP14 MSH2 GFPT1 GTF2F1 SUPT16H SPATS2 EIF3I SNRPA HSPA1A TOP1 GOLGB1 VDAC2 | 8.14e-07 | 1415 | 150 | 21 | 28515276 |
| Pubmed | PDCD6IP COPG1 RPN2 CPSF6 SMCHD1 POLR2A STK38 TRIM27 PRICKLE2 FGD5 SNRPA HSPA1A STAG3 GOLGB1 VDAC2 | 1.04e-06 | 754 | 150 | 15 | 35906200 | |
| Pubmed | ATXN2L UACA MAT2B PUF60 CPSF6 IFT74 FSIP2 YLPM1 SNRPA HSPA1A HSPA1B | 1.41e-06 | 399 | 150 | 11 | 35987950 | |
| Pubmed | ATXN2L PDCD6IP UACA RPN2 PUF60 CPSF6 POLR2A MSH2 GFPT1 DNAH1 AHR OXSM MARK2 SPATS2 EIF3I HSPA1A ZNF281 TOP1 VDAC2 | 1.95e-06 | 1247 | 150 | 19 | 27684187 | |
| Pubmed | ATXN2L DDX31 UACA COPG1 PUF60 CPSF6 SMCHD1 BMS1 SRP14 NOL10 GFPT1 LENG8 YLPM1 SUPT16H AHR DLST MARK2 SPATS2 TOP1 VDAC2 | 1.98e-06 | 1371 | 150 | 20 | 36244648 | |
| Pubmed | ZNF148 IFT74 INPP5F KIF20B SFMBT2 RAB3GAP2 HSPA1A HSPA1B GOLGB1 KNL1 PCNT | 2.22e-06 | 418 | 150 | 11 | 34709266 | |
| Pubmed | 2.38e-06 | 339 | 150 | 10 | 30415952 | ||
| Pubmed | ATXN2L AARS1 PDCD6IP COPG1 PUF60 CPSF6 SMCHD1 SRP14 EIF3I SNRPA HSPA1A HSPA1B TOP1 VDAC2 | 2.55e-06 | 707 | 150 | 14 | 19738201 | |
| Pubmed | ATXN2L PDCD6IP RPN2 STK38 SRP14 OCRL GFPT1 RAB3GAP2 ROBO1 MARK2 HSPA1B TOP1 GOLGB1 VDAC2 | 2.60e-06 | 708 | 150 | 14 | 39231216 | |
| Pubmed | 2.72e-06 | 7 | 150 | 3 | 9256245 | ||
| Pubmed | AARS1 COPG1 PUF60 CPSF6 SMCHD1 FASTKD2 GFPT1 GTF2F1 SUPT16H DLST EIF3I HSPA1B GOLGB1 VDAC2 | 2.73e-06 | 711 | 150 | 14 | 33022573 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | ATXN2L AARS1 PUF60 CPSF6 POLR2A STK38 SUPT16H DLST EIF3I SNRPA HSPA1A HSPA1B TOP1 VDAC2 | 2.86e-06 | 714 | 150 | 14 | 28302793 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ATXN2L DDX31 POLR1A ATRX POLR2A SRP14 GFPT1 LENG8 YLPM1 SUPT16H MIOS | 3.62e-06 | 440 | 150 | 11 | 34244565 |
| Pubmed | ATXN2L ATRX POLR2A BMS1 STK38 SRP14 MSH2 GTF2F1 EIF3I HSPA1A TOP1 | 3.70e-06 | 441 | 150 | 11 | 31239290 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | PDCD6IP RPN2 PUF60 CPSF6 POLR2A BMS1 STK38 SRP14 YLPM1 SUPT16H MIOS DLST SNRPA ZNF281 TOP1 VDAC2 ZNF292 | 4.71e-06 | 1082 | 150 | 17 | 38697112 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | ZNF148 PDCD6IP SMCHD1 POLR2A NOL10 KIF20B LENG8 MARK2 SNRPA TOP1 | 5.15e-06 | 370 | 150 | 10 | 22922362 |
| Pubmed | 5.57e-06 | 102 | 150 | 6 | 10231032 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | POLR1A PDCD6IP ATRX RASA2 UACA WASF3 ASH1L RILPL1 PDE10A ESCO1 SFMBT2 DNAH14 DNAH1 ATP11B GUCY1A1 FNIP1 SPATS2 STK38L GOLGB1 PCNT | 6.79e-06 | 1489 | 150 | 20 | 28611215 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ATXN2L AARS1 PDCD6IP COPG1 RPN2 PUF60 CPSF6 IFT74 BMS1 GFPT1 S100A11 YLPM1 SUPT16H DLST EIF3I HSPA1A GOLGB1 VDAC2 KNL1 | 7.28e-06 | 1367 | 150 | 19 | 32687490 |
| Pubmed | The interactome of the prostate-specific protein Anoctamin 7. | 9.36e-06 | 65 | 150 | 5 | 32176628 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ATXN2L DDX31 ATRX IFT74 TPRN KIF20B GTF2F1 EIF3I GOLGB1 KNL1 PCNT SORL1 | 1.01e-05 | 588 | 150 | 12 | 38580884 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | AARS1 POLR1A CPSF6 POLR2A SMC5 CBR3 TGM5 DNAH12 KIAA0825 MARK2 ZNF292 | 1.14e-05 | 497 | 150 | 11 | 36774506 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | AARS1 PDCD6IP COPG1 RPN2 PUF60 CPSF6 POLR2A ASH1L GFPT1 DNAH1 S100A11 HSPA1B TOP1 VDAC2 | 1.15e-05 | 807 | 150 | 14 | 30575818 |
| Pubmed | AARS1 ATP6V0A1 ATRX IFT74 ASH1L RILPL1 CBR3 GFPT1 HECTD2 YLPM1 ROBO1 DLST HSPA1A HSPA1B TOP1 DOP1B ZNF292 PCNT | 1.16e-05 | 1285 | 150 | 18 | 35914814 | |
| Pubmed | ATXN2L AARS1 UACA RPN2 PUF60 SMCHD1 SRP14 MSH2 KIF20B YLPM1 DLST EIF3I SNRPA TOP1 | 1.18e-05 | 809 | 150 | 14 | 32129710 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | DDX31 ZNF148 PDCD6IP RPN2 KIF20B LENG8 YLPM1 MARK2 SPATS2 VDAC2 | 1.26e-05 | 410 | 150 | 10 | 26949251 |
| Pubmed | 1.43e-05 | 251 | 150 | 8 | 31076518 | ||
| Pubmed | NBPF8 COL6A3 AARS1 FRMPD4 ABCA12 ABCA13 CPSF6 SMCHD1 CBR3 OXSM TOP1 | 1.53e-05 | 513 | 150 | 11 | 25798074 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.63e-05 | 123 | 150 | 6 | 26912792 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.65e-05 | 256 | 150 | 8 | 33397691 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ATXN2L POLR1A UACA COPG1 RPN2 OCRL SMC5 TRIM27 YLPM1 SPATS2 ZNF281 TOP1 ZNF292 | 1.67e-05 | 724 | 150 | 13 | 36232890 |
| Pubmed | Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. | 1.85e-05 | 2 | 150 | 2 | 12411538 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 2868009 | ||
| Pubmed | Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients. | 1.85e-05 | 2 | 150 | 2 | 24328534 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 3786141 | ||
| Pubmed | NDR functions as a physiological YAP1 kinase in the intestinal epithelium. | 1.85e-05 | 2 | 150 | 2 | 25601544 | |
| Pubmed | Characterization of the binding between a 70-kDa heat shock protein, HspA1A, and phosphoinositides. | 1.85e-05 | 2 | 150 | 2 | 26923070 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 16482515 | ||
| Pubmed | Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. | 1.85e-05 | 2 | 150 | 2 | 11864979 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 15719414 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 26976620 | ||
| Pubmed | Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. | 1.85e-05 | 2 | 150 | 2 | 21187371 | |
| Pubmed | RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription. | 1.85e-05 | 2 | 150 | 2 | 27058666 | |
| Pubmed | Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer. | 1.85e-05 | 2 | 150 | 2 | 20430459 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 20235222 | ||
| Pubmed | Genetic determinants of HSP70 gene expression following heat shock. | 1.85e-05 | 2 | 150 | 2 | 20876613 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 20223214 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 20093776 | ||
| Pubmed | Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells. | 1.85e-05 | 2 | 150 | 2 | 23704948 | |
| Pubmed | Structure and expression of the human gene encoding major heat shock protein HSP70. | 1.85e-05 | 2 | 150 | 2 | 2858050 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 17513788 | ||
| Pubmed | IL-6 activates HSP72 gene expression in human skeletal muscle. | 1.85e-05 | 2 | 150 | 2 | 12207910 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 28837204 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 29572464 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 15988927 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 26448330 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 12714332 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 19299581 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 11713291 | ||
| Pubmed | Heat shock protein 72 (Hsp72) improves long term recovery after focal cerebral ischemia in mice. | 1.85e-05 | 2 | 150 | 2 | 21108992 | |
| Pubmed | Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70). | 1.85e-05 | 2 | 150 | 2 | 31320473 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 16971451 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 29631603 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 21757701 | ||
| Pubmed | Zfp281 and Zfp148 control CD4+ T cell thymic development and TH2 functions. | 1.85e-05 | 2 | 150 | 2 | 37948511 | |
| Pubmed | Role of membrane Hsp70 in radiation sensitivity of tumor cells. | 1.85e-05 | 2 | 150 | 2 | 26197988 | |
| Pubmed | Hsp72 overexpression accelerates the recovery from caerulein-induced pancreatitis. | 1.85e-05 | 2 | 150 | 2 | 22792201 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 31415918 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 9820195 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 19157555 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 37298493 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 25618331 | ||
| Pubmed | Extracellular heat shock protein 72 is a marker of the stress protein response in acute lung injury. | 1.85e-05 | 2 | 150 | 2 | 16679378 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 19639652 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 16100242 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 15498567 | ||
| Pubmed | Biological activity of truncated C-terminus human heat shock protein 72. | 1.85e-05 | 2 | 150 | 2 | 21094186 | |
| Pubmed | Geranylgeranylaceton induces heat shock protein 72 in skeletal muscle cells. | 1.85e-05 | 2 | 150 | 2 | 17482577 | |
| Interaction | NAA40 interactions | ATXN2L AARS1 ZNF148 ATRX PUF60 CPSF6 SMCHD1 POLR2A OCRL SMC5 GFPT1 LENG8 YLPM1 SUPT16H EIF3I HSPA1A ZNF281 TOP1 GOLGB1 VDAC2 KNL1 PCNT | 2.46e-06 | 978 | 147 | 22 | int:NAA40 |
| Interaction | HAPSTR1 interactions | ATXN2L AARS1 ZNF148 PDCD6IP EID3 ATRX COPG1 RPN2 CPSF6 ZNF175 SRP14 MSH2 YLPM1 SUPT16H MARK2 HSPA1A HSPA1B ABTB2 DOP1B SORL1 | 2.61e-06 | 829 | 147 | 20 | int:HAPSTR1 |
| Interaction | TCERG1 interactions | 2.94e-06 | 207 | 147 | 10 | int:TCERG1 | |
| Interaction | SMC5 interactions | ATXN2L ZNF148 EID3 ATRX PUF60 CPSF6 SMCHD1 POLR2A SRP14 NOL10 SMC5 KIF20B LENG8 YLPM1 SUPT16H EIF3I SNRPA HSPA1A ZNF281 TOP1 VDAC2 KNL1 | 3.53e-06 | 1000 | 147 | 22 | int:SMC5 |
| Interaction | SETD2 interactions | 6.72e-06 | 135 | 147 | 8 | int:SETD2 | |
| Interaction | SIRT7 interactions | ATXN2L AARS1 DDX31 POLR1A PDCD6IP COPG1 RPN2 PUF60 SMCHD1 POLR2A BMS1 NOL10 MSH2 GFPT1 YLPM1 EIF3I TOP1 PCNT | 8.30e-06 | 744 | 147 | 18 | int:SIRT7 |
| Interaction | CSTF1 interactions | 1.12e-05 | 104 | 147 | 7 | int:CSTF1 | |
| Interaction | HDLBP interactions | UACA COPG1 RPN2 PUF60 CPSF6 SMCHD1 SRP14 BIRC3 SMC5 GFPT1 LENG8 S100A11 YLPM1 SUPT16H MARK2 SPATS2 HSPA1A TOP1 VDAC2 | 1.52e-05 | 855 | 147 | 19 | int:HDLBP |
| Interaction | EED interactions | AARS1 ATP6V0A1 PDCD6IP COPG1 RPN2 PUF60 CPSF6 SMCHD1 POLR2A STK38 SRP14 NOL10 MSH2 SMC5 KIF20B GFPT1 RAB3GAP2 YLPM1 SUPT16H TRIM55 MARK2 EIF3I SNRPA TOP1 VDAC2 PCNT | 1.58e-05 | 1445 | 147 | 26 | int:EED |
| Interaction | LTK interactions | 1.60e-05 | 152 | 147 | 8 | int:LTK | |
| Interaction | EIF4A3 interactions | AARS1 CPSF6 BMS1 STK38 SRP14 BIRC3 NOL10 SMC5 TRIM27 DLST SNRPA STK38L HSPA1A TOP1 | 1.79e-05 | 499 | 147 | 14 | int:EIF4A3 |
| Interaction | NOP56 interactions | DDX31 ATRX RPN2 PUF60 BMS1 SRP14 BIRC3 NOL10 SMC5 LENG8 GTF2F1 P2RX5 SUPT16H DLST TOP1 | 1.88e-05 | 570 | 147 | 15 | int:NOP56 |
| Interaction | CHMP4B interactions | ATP6V0A1 PDCD6IP ATRX PUF60 BMS1 SRP14 BIRC3 TRIM27 GFPT1 SUPT16H DLST HSPA1A ZNF281 STAG3 TOP1 GOLGB1 PMFBP1 | 2.33e-05 | 727 | 147 | 17 | int:CHMP4B |
| Interaction | H2BC9 interactions | TMC1 ATRX ABCA13 POLR2A ASH1L OCRL TEX15 SMC5 SFMBT2 DNAH1 FSIP2 YLPM1 SUPT16H | 2.43e-05 | 446 | 147 | 13 | int:H2BC9 |
| Interaction | RBM25 interactions | ATXN2L PUF60 CPSF6 BIRC3 MSH2 SMC5 RAB3GAP2 SUPT16H MARK2 SNRPA TOP1 | 2.58e-05 | 323 | 147 | 11 | int:RBM25 |
| Interaction | IK interactions | 2.92e-05 | 215 | 147 | 9 | int:IK | |
| Interaction | SNU13 interactions | CPSF6 POLR2A SRP14 BIRC3 SMC5 SUPT16H TRIM55 DLST SNRPA TOP1 | 4.73e-05 | 285 | 147 | 10 | int:SNU13 |
| Interaction | POLR1G interactions | DDX31 POLR1A SMCHD1 POLR2A BMS1 NOL10 MSH2 KIF20B GTF2F1 SUPT16H ZNF281 TOP1 ZNF292 | 6.25e-05 | 489 | 147 | 13 | int:POLR1G |
| Interaction | HNRNPU interactions | DDX31 CPSF6 POLR2A BIRC3 TNFAIP8L1 FASTKD2 MSH2 SMC5 ITGAL DNAH1 GTF2F1 DCUN1D1 SUPT16H TRIM55 SPATS2 SNRPA HSPA1A TOP1 GOLGB1 VDAC2 | 6.46e-05 | 1035 | 147 | 20 | int:HNRNPU |
| Interaction | KCNA3 interactions | ATXN2L PDCD6IP RPN2 ABCA13 PUF60 STK38 SRP14 MSH2 OCRL GFPT1 RAB3GAP2 ROBO1 MARK2 HSPA1B TOP1 GOLGB1 VDAC2 SORL1 | 6.64e-05 | 871 | 147 | 18 | int:KCNA3 |
| Interaction | NR2C2 interactions | DDX31 ZNF148 POLR1A PDCD6IP COPG1 RPN2 PUF60 CPSF6 SMCHD1 BMS1 SRP14 NOL10 FASTKD2 MSH2 SMC5 TAMM41 SUPT16H TRIM55 TIFA EIF3I SNRPA HSPA1A TOP1 VDAC2 | 7.82e-05 | 1403 | 147 | 24 | int:NR2C2 |
| Interaction | MKI67 interactions | DDX31 ZNF148 PDCD6IP RPN2 BIRC3 SMC5 CBR3 KIF20B LENG8 YLPM1 TRIM55 MARK2 SPATS2 TOP1 VDAC2 | 8.09e-05 | 648 | 147 | 15 | int:MKI67 |
| Interaction | RPRD2 interactions | 9.91e-05 | 146 | 147 | 7 | int:RPRD2 | |
| Interaction | SUPT16H interactions | POLR1A ATRX POLR2A BIRC3 MSH2 TEX15 SMC5 SUPT16H ETAA1 SNRPA HSPA1A TOP1 | 9.91e-05 | 442 | 147 | 12 | int:SUPT16H |
| Interaction | CEBPA interactions | ATXN2L AARS1 ZNF148 MAT2B RPN2 PUF60 CPSF6 SMCHD1 POLR2A SRP14 NOL10 MSH2 LENG8 S100A11 GTF2F1 RAB3GAP2 SNRPA HSPA1B ZNF281 TOP1 KNL1 ZNF292 | 1.01e-04 | 1245 | 147 | 22 | int:CEBPA |
| Interaction | H3C1 interactions | DDX31 ATRX SMCHD1 POLR2A ASH1L SRP14 MSH2 SMC5 ESCO1 KIF20B DNAH1 GTF2F1 SUPT16H SNRPA ZNF281 DNAH8 TOP1 ZNF292 | 1.02e-04 | 901 | 147 | 18 | int:H3C1 |
| Interaction | PRPF40A interactions | ATXN2L PUF60 CPSF6 WASF3 BIRC3 SMC5 RAB3GAP2 YLPM1 MARK2 SNRPA HSPA1A TOP1 | 1.08e-04 | 446 | 147 | 12 | int:PRPF40A |
| Interaction | SMARCC1 interactions | CPSF6 POLR2A BIRC3 SMC5 GTF2F1 SLC15A2 RAB3GAP2 YLPM1 SUPT16H HSPA1A TOP1 | 1.22e-04 | 384 | 147 | 11 | int:SMARCC1 |
| Interaction | LAMTOR5 interactions | 1.33e-04 | 153 | 147 | 7 | int:LAMTOR5 | |
| Interaction | APEX1 interactions | ATP6V0A1 DDX31 ZNF148 UACA PUF60 CPSF6 IFT74 SMCHD1 BMS1 NOL10 RILPL1 SMC5 KIF20B DNAH14 LENG8 USP6 GTF2F1 TAMM41 MARK2 HSPA1A ZNF281 ZNF292 | 1.36e-04 | 1271 | 147 | 22 | int:APEX1 |
| Interaction | THOC1 interactions | 1.57e-04 | 210 | 147 | 8 | int:THOC1 | |
| Interaction | MECP2 interactions | ATXN2L DDX31 PDCD6IP ATRX RPN2 PUF60 CPSF6 POLR2A BMS1 STK38 SRP14 SMC5 LENG8 YLPM1 SUPT16H MIOS DLST SNRPA ZNF281 TOP1 VDAC2 ZNF292 | 1.63e-04 | 1287 | 147 | 22 | int:MECP2 |
| Interaction | CDC5L interactions | COPG1 CPSF6 SMCHD1 POLR2A BMS1 SRP14 BIRC3 MSH2 SMC5 YLPM1 TRIM55 MARK2 SNRPA TOP1 GOLGB1 KNL1 PCNT | 1.70e-04 | 855 | 147 | 17 | int:CDC5L |
| Interaction | KDM1A interactions | ZNF148 IFT74 POLR2A BIRC3 SOCS6 INPP5F ESCO1 KIF20B SFMBT2 LENG8 BMP3 RAB3GAP2 SUPT16H HSPA1A HSPA1B GOLGB1 KNL1 PCNT | 1.75e-04 | 941 | 147 | 18 | int:KDM1A |
| Interaction | SF3A1 interactions | PUF60 SMCHD1 BIRC3 MSH2 OCRL SMC5 GTF2F1 YLPM1 SUPT16H TRIM55 SNRPA HSPA1A | 1.79e-04 | 471 | 147 | 12 | int:SF3A1 |
| Interaction | SMURF1 interactions | DDX31 TAPT1 RPN2 CPSF6 POLR2A STK38 PIP5K1C MARK2 SNRPA STK38L HSPA1A HSPA1B VDAC2 | 1.80e-04 | 544 | 147 | 13 | int:SMURF1 |
| Interaction | ANO7 interactions | 1.82e-04 | 72 | 147 | 5 | int:ANO7 | |
| Interaction | NUP43 interactions | DDX31 IFT74 ASH1L BMS1 NOL10 CCDC168 RILPL1 FSIP2 RAB3GAP2 SUPT16H ZNF281 TOP1 KNL1 ZNF292 | 1.98e-04 | 625 | 147 | 14 | int:NUP43 |
| Interaction | WWOX interactions | PDCD6IP ATRX DSG3 RPN2 CPSF6 POLR2A MSH2 SMC5 GFPT1 LENG8 SLC15A2 YLPM1 HSPA1A VDAC2 | 2.05e-04 | 627 | 147 | 14 | int:WWOX |
| Interaction | SUPT5H interactions | ATRX CPSF6 POLR2A BIRC3 MSH2 LENG8 SUPT16H MIOS SNRPA HSPA1A TOP1 | 2.06e-04 | 408 | 147 | 11 | int:SUPT5H |
| Interaction | TERF2IP interactions | ZNF148 PUF60 SMCHD1 SRP14 MSH2 KIF20B GTF2F1 AHR SNRPA ZNF281 TOP1 KNL1 ZNF292 | 2.08e-04 | 552 | 147 | 13 | int:TERF2IP |
| Interaction | COIL interactions | DDX31 ZNF148 BMS1 BIRC3 NOL10 MSH2 SMC5 GTF2F1 SUPT16H ZNF281 TOP1 VDAC2 ZNF292 | 2.08e-04 | 552 | 147 | 13 | int:COIL |
| Interaction | SIRT6 interactions | ATXN2L DDX31 POLR1A ATRX POLR2A SRP14 MSH2 TRIM27 GFPT1 LENG8 YLPM1 SUPT16H AHR MIOS | 2.08e-04 | 628 | 147 | 14 | int:SIRT6 |
| Interaction | IWS1 interactions | 2.09e-04 | 116 | 147 | 6 | int:IWS1 | |
| Interaction | RBM39 interactions | ATXN2L AARS1 ATRX RPN2 PUF60 CPSF6 POLR2A STK38 BIRC3 SMC5 YLPM1 SUPT16H DLST EIF3I SNRPA HSPA1A HSPA1B TOP1 VDAC2 | 2.11e-04 | 1042 | 147 | 19 | int:RBM39 |
| Interaction | SUPT6H interactions | 2.16e-04 | 220 | 147 | 8 | int:SUPT6H | |
| Interaction | SNRPA interactions | PUF60 POLR2A BIRC3 TNFAIP8L1 SMC5 TRIM27 LENG8 GTF2F1 YLPM1 SUPT16H SNRPA TOP1 | 2.22e-04 | 482 | 147 | 12 | int:SNRPA |
| Interaction | PARP1 interactions | DDX31 ZNF148 POLR1A PDCD6IP CPSF6 SMCHD1 POLR2A BMS1 BIRC3 NOL10 MSH2 SMC5 GTF2F1 RAB3GAP2 SUPT16H AHR MARK2 HSPA1A ZNF281 STAG3 TOP1 ZNF292 | 2.23e-04 | 1316 | 147 | 22 | int:PARP1 |
| Interaction | SNRPD2 interactions | PUF60 CPSF6 POLR2A SRP14 BIRC3 SMC5 DCUN1D1 SUPT16H SNRPA HSPA1A TOP1 | 2.34e-04 | 414 | 147 | 11 | int:SNRPD2 |
| Interaction | ARHGAP24 interactions | ATXN2L AARS1 PDCD6IP COPG1 RPN2 PUF60 CPSF6 GFPT1 MIOS HSPA1A HSPA1B TOP1 | 2.39e-04 | 486 | 147 | 12 | int:ARHGAP24 |
| Interaction | CCNT1 interactions | 2.51e-04 | 225 | 147 | 8 | int:CCNT1 | |
| Interaction | BORCS6 interactions | 2.54e-04 | 170 | 147 | 7 | int:BORCS6 | |
| Interaction | CAAP1 interactions | 2.69e-04 | 43 | 147 | 4 | int:CAAP1 | |
| Interaction | BIRC3 interactions | AARS1 DENND4A POLR1A PDCD6IP COPG1 MAT2B RPN2 PUF60 SMCHD1 POLR2A BMS1 SRP14 BIRC3 NOL10 FASTKD2 MSH2 GFPT1 SUPT16H DLST EIF3I SNRPA VDAC2 | 2.69e-04 | 1334 | 147 | 22 | int:BIRC3 |
| Interaction | SEPTIN7 interactions | 2.75e-04 | 228 | 147 | 8 | int:SEPTIN7 | |
| Interaction | GLI4 interactions | 3.13e-04 | 125 | 147 | 6 | int:GLI4 | |
| Interaction | GOLGA2P5 interactions | 3.14e-04 | 4 | 147 | 2 | int:GOLGA2P5 | |
| Interaction | RPS3A interactions | DDX31 ASH1L BMS1 BIRC3 TNFAIP8L1 NOL10 SMC5 TRIM27 GTF2F1 DCUN1D1 FGD5 HSPA1A TOP1 VDAC2 | 3.19e-04 | 655 | 147 | 14 | int:RPS3A |
| Interaction | CRNKL1 interactions | 3.25e-04 | 177 | 147 | 7 | int:CRNKL1 | |
| Interaction | GTF2F1 interactions | 3.27e-04 | 234 | 147 | 8 | int:GTF2F1 | |
| Interaction | FOXP3 interactions | ZNF148 PDCD6IP SMCHD1 POLR2A NOL10 KIF20B LENG8 MARK2 SNRPA HSPA1A TOP1 | 3.36e-04 | 432 | 147 | 11 | int:FOXP3 |
| Interaction | TTN interactions | 3.56e-04 | 299 | 147 | 9 | int:TTN | |
| Interaction | SMN1 interactions | 3.56e-04 | 299 | 147 | 9 | int:SMN1 | |
| Interaction | ACIN1 interactions | 3.74e-04 | 301 | 147 | 9 | int:ACIN1 | |
| Interaction | H1-2 interactions | DENND4A DDX31 ATRX ABCA13 PUF60 POLR2A BMS1 BIRC3 NOL10 SMC5 KIF20B GTF2F1 SLC15A2 TOP1 | 3.77e-04 | 666 | 147 | 14 | int:H1-2 |
| Interaction | PNN interactions | 3.83e-04 | 302 | 147 | 9 | int:PNN | |
| Interaction | ILF2 interactions | DDX31 PUF60 CPSF6 BIRC3 FASTKD2 SMC5 TRIM27 ESCO1 DCUN1D1 DLST SNRPA HSPA1A TOP1 | 3.94e-04 | 590 | 147 | 13 | int:ILF2 |
| Interaction | FNIP2 interactions | 3.96e-04 | 20 | 147 | 3 | int:FNIP2 | |
| Interaction | SAP18 interactions | 4.11e-04 | 305 | 147 | 9 | int:SAP18 | |
| Interaction | SAFB interactions | 4.32e-04 | 244 | 147 | 8 | int:SAFB | |
| Interaction | XAB2 interactions | 4.38e-04 | 186 | 147 | 7 | int:XAB2 | |
| Interaction | ZNF330 interactions | DDX31 ZNF148 SMCHD1 BMS1 NOL10 GTF2F1 SUPT16H HSPA1A ZNF281 TOP1 ZNF292 | 4.40e-04 | 446 | 147 | 11 | int:ZNF330 |
| Interaction | SMC6 interactions | 4.41e-04 | 87 | 147 | 5 | int:SMC6 | |
| Interaction | ACE2 interactions | ATXN2L PDCD6IP RPN2 PUF60 BMS1 SRP14 MSH2 OCRL S100A11 YLPM1 SUPT16H CFAP57 EIF3I SNRPA HSPA1A HSPA1B TOP1 GOLGB1 VDAC2 | 4.44e-04 | 1106 | 147 | 19 | int:ACE2 |
| Interaction | CWC15 interactions | 4.54e-04 | 134 | 147 | 6 | int:CWC15 | |
| Interaction | CENPA interactions | DDX31 ZNF148 ATRX SMCHD1 BMS1 NOL10 GTF2F1 SUPT16H TOP1 ZNF292 | 4.57e-04 | 377 | 147 | 10 | int:CENPA |
| Interaction | API5 interactions | 4.67e-04 | 188 | 147 | 7 | int:API5 | |
| Interaction | POLR2I interactions | 4.72e-04 | 135 | 147 | 6 | int:POLR2I | |
| Interaction | DHX40 interactions | 4.95e-04 | 249 | 147 | 8 | int:DHX40 | |
| Interaction | MEN1 interactions | ATXN2L DDX31 ZNF148 ATRX CPSF6 SMCHD1 POLR2A BMS1 SRP14 NOL10 MSH2 LENG8 YLPM1 SUPT16H DLST SPATS2 ZNF281 TOP1 | 5.13e-04 | 1029 | 147 | 18 | int:MEN1 |
| Interaction | RAD18 interactions | COPG1 CPSF6 SRP14 MSH2 SMC5 LENG8 SUPT16H SNRPA HSPA1A HSPA1B TOP1 | 5.39e-04 | 457 | 147 | 11 | int:RAD18 |
| Interaction | SART1 interactions | 5.43e-04 | 317 | 147 | 9 | int:SART1 | |
| Interaction | TNIP1 interactions | ATXN2L AARS1 POLR1A FRMPD4 UACA COPG1 PUF60 CPSF6 TPRN SRP14 NOL10 GFPT1 LENG8 SUPT16H MARK2 SNRPA HSPA1A HSPA1B TOP1 VDAC2 | 5.48e-04 | 1217 | 147 | 20 | int:TNIP1 |
| Interaction | CSTF3 interactions | 5.51e-04 | 139 | 147 | 6 | int:CSTF3 | |
| GeneFamily | Dyneins, axonemal | 2.12e-08 | 17 | 95 | 5 | 536 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 2.97e-04 | 25 | 95 | 3 | 504 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.46e-03 | 11 | 95 | 2 | 1168 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | NPL MOSPD2 RASA2 UACA ZNF175 ASH1L EBF1 RILPL1 PDE10A ESCO1 KLHL5 GUCY1A1 RAPGEF3 RAB3GAP2 ARHGAP28 FGD5 HSPA1A HSPA1B | 1.84e-06 | 854 | 149 | 18 | M1533 |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | COL6A3 PDCD6IP MAT2B SMCHD1 POLR2A STK38 FASTKD2 P2RX5 SORL1 | 2.27e-06 | 200 | 149 | 9 | M4449 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | NPL MOSPD2 RASA2 UACA ZNF175 ASH1L EBF1 RILPL1 PDE10A ESCO1 KLHL5 GUCY1A1 RAPGEF3 RAB3GAP2 ARHGAP28 FGD5 HSPA1A HSPA1B | 3.17e-06 | 888 | 149 | 18 | MM1018 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ZNF148 ATRX SMCHD1 WASF3 MSH2 INPP5F SMC5 KIF20B USP6 ATP11B DOP1B ZNF292 | 1.53e-05 | 466 | 149 | 12 | M13522 |
| Coexpression | SMIRNOV_RESPONSE_TO_IR_2HR_DN | 1.83e-05 | 57 | 149 | 5 | M2586 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.00e-05 | 275 | 145 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.24e-05 | 291 | 145 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | FNIP2 SPATA7 ATXN2L ATRX SMCHD1 POLR2A NOL10 EFCAB14 KLHL5 YLPM1 DLST GOLGB1 KNL1 ZNF292 | 3.33e-05 | 564 | 145 | 14 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 5.35e-05 | 192 | 145 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ATRX IFT74 SMC5 KIF20B KLHL5 HECTD2 SUPT16H TOP1 KNL1 ZNF292 | 5.67e-05 | 311 | 145 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305 | 9.14e-05 | 266 | 145 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_200 | 9.26e-05 | 35 | 145 | 4 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | SPATA7 ATRX UACA FASTKD2 EFCAB14 SMC5 KIF20B RAPGEF3 SUPT16H ETAA1 TOP1 ZNF292 | 9.33e-05 | 469 | 145 | 12 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 9.37e-05 | 107 | 145 | 6 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | DENND4A MOSPD2 DDX31 ZNF148 CPSF6 NOL10 GFPT1 YLPM1 SUPT16H FNIP1 ROBO1 ZNF292 | 1.46e-04 | 492 | 145 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | SPATA7 ATRX EFCAB14 SMC5 KIF20B KLHL5 YLPM1 TOP1 GOLGB1 KNL1 ZNF292 | 1.92e-04 | 432 | 145 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | FNIP2 SPATA7 ATRX SMCHD1 POLR2A MSH2 EFCAB14 INPP5F KLHL5 ATP11B YLPM1 GOLGB1 ZNF292 | 2.27e-04 | 595 | 145 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.67e-07 | 178 | 150 | 8 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 2.98e-07 | 192 | 150 | 8 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 3.22e-07 | 194 | 150 | 8 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.35e-07 | 195 | 150 | 8 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.85e-07 | 150 | 150 | 7 | 6c39e73a0b05d4b26589f333ce13924e3d373b8d | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.43e-06 | 164 | 150 | 7 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.18e-06 | 185 | 150 | 7 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-06 | 191 | 150 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.92e-06 | 191 | 150 | 7 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-06 | 191 | 150 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 4.20e-06 | 193 | 150 | 7 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.35e-06 | 194 | 150 | 7 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-06 | 194 | 150 | 7 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | distal-Epithelial-Proximal_Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.50e-06 | 195 | 150 | 7 | abe7998421dc59bdae35c0c2251c4a1ebef5e021 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.50e-06 | 195 | 150 | 7 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | distal-Epithelial-Proximal_Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.50e-06 | 195 | 150 | 7 | 0e3f74e0877d33c11f048b9be8394596cf5c9c4c | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.65e-06 | 196 | 150 | 7 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 5.14e-06 | 199 | 150 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.14e-06 | 199 | 150 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.86e-06 | 145 | 150 | 6 | 9743d68ba8bfef56fd9a979ab357c0e287eb5ae2 | |
| ToppCell | control-B_cell|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.55e-05 | 157 | 150 | 6 | 1269b55f2ef6a493f6116b131cc5cc7b8897d63e | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.59e-05 | 172 | 150 | 6 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.77e-05 | 174 | 150 | 6 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.86e-05 | 175 | 150 | 6 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 176 | 150 | 6 | 29cda51a99100ddd2928cadc92da40f001d7e1f4 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 176 | 150 | 6 | 01774a86d7d92f31a056b753f9844f923038003e | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.15e-05 | 178 | 150 | 6 | 812e261d9cbdc74fafe3c5c3422151c1cfacb22d | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.15e-05 | 178 | 150 | 6 | 5d41fede13c8e64b6fdaf2155f1eb72bcfc32fdb | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 3.35e-05 | 180 | 150 | 6 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-05 | 180 | 150 | 6 | 729f0d7af573c7796d8e28e6eec3af2fc0bd33a2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-05 | 180 | 150 | 6 | 9ef79a7c60227e352ac166c7274adb31f585f5ca | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.45e-05 | 181 | 150 | 6 | d66838fca0429cad2079cd8d92a5cd33eb0d3522 | |
| ToppCell | COVID-19_Moderate-B_memory|COVID-19_Moderate / disease group, cell group and cell class | 3.56e-05 | 182 | 150 | 6 | bbdbef62389ac062118cc0c7979686393399f2c8 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 3.56e-05 | 182 | 150 | 6 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | ICU-NoSEP-Lymphocyte-B-B_memory|ICU-NoSEP / Disease, Lineage and Cell Type | 3.67e-05 | 183 | 150 | 6 | c6d1d0779c46e08d2235b6dd342a7ec25911864c | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-05 | 183 | 150 | 6 | f55081068213cc1cdb2acad58ff10f6b48b44c72 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-B_memory-3|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.90e-05 | 185 | 150 | 6 | 05e6eb78ead81268c1656e7ffe34f9cb7329b908 | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.90e-05 | 185 | 150 | 6 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.14e-05 | 187 | 150 | 6 | ea56cfca919a09db852b7ee5e42323f822962465 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 4.14e-05 | 187 | 150 | 6 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.14e-05 | 187 | 150 | 6 | 43f81863063509337bd56a67010c62fb51109bd5 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.27e-05 | 188 | 150 | 6 | 599195338070ac6b79bd114609d9e10cac4f1df4 | |
| ToppCell | normal-na-Lymphocytic_B-B_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.27e-05 | 188 | 150 | 6 | ec72ba73b10c6f2ff39699b6b46b90a3e95a4c24 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.27e-05 | 188 | 150 | 6 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.40e-05 | 189 | 150 | 6 | e2bb5900d210386b7b74938e7a3636d0c7ba1bcf | |
| ToppCell | remission-B_memory|remission / disease stage, cell group and cell class | 4.40e-05 | 189 | 150 | 6 | a7b434a5d2cc7c3952cb8f16d11219b691c6c2b6 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.53e-05 | 190 | 150 | 6 | 17829f4de31b3d9e4d71ba4817d18842aa699773 | |
| ToppCell | severe-B_naive|World / disease stage, cell group and cell class | 4.53e-05 | 190 | 150 | 6 | 8dfe067d75573289299a5fba42b6c9b26e5fb430 | |
| ToppCell | remission-B_memory|World / disease stage, cell group and cell class | 4.53e-05 | 190 | 150 | 6 | c3f55f752e47b5a71e111367cdbed4a39ab5cb21 | |
| ToppCell | B_cell_maturation|World / Lineage and Cell class | 4.53e-05 | 190 | 150 | 6 | 301782283d0c604fb3b428a8ddf1f7cd8e63a90b | |
| ToppCell | severe-B_naive|severe / disease stage, cell group and cell class | 4.53e-05 | 190 | 150 | 6 | 2430a1fd18385305bf1b604747ff64026a8d5edf | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.66e-05 | 191 | 150 | 6 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.66e-05 | 191 | 150 | 6 | b374676ac90572d65895052d46469906e2b6fd93 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_B-B_memory|COVID-19_Convalescent / Disease group, lineage and cell class | 4.66e-05 | 191 | 150 | 6 | 4a853cd2434b0f5b18e1f853c37515845046c88b | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.66e-05 | 191 | 150 | 6 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.80e-05 | 192 | 150 | 6 | 446c61c0d6ba89c619efe87ee495951299953981 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_mem|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.80e-05 | 192 | 150 | 6 | 75ce635d669ff77d1fd54e10467f21d5e5d67b08 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.80e-05 | 192 | 150 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_mem-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.80e-05 | 192 | 150 | 6 | 80a71ab3434076803466ccac0df73468889c7dd3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.94e-05 | 193 | 150 | 6 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.08e-05 | 194 | 150 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | COVID-19_Severe-B_naive|World / disease group, cell group and cell class | 5.08e-05 | 194 | 150 | 6 | d363963a6caeedf4f9e9ad22dcf9b66b85c79a48 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 5.08e-05 | 194 | 150 | 6 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-05 | 195 | 150 | 6 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | severe-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.23e-05 | 195 | 150 | 6 | 73e39005a597e13aea571ae6ae5824d1c7448b71 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.23e-05 | 195 | 150 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.23e-05 | 195 | 150 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-05 | 195 | 150 | 6 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.23e-05 | 195 | 150 | 6 | 1e28617ca55e5f318a228357737b968dfac8cca0 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.38e-05 | 196 | 150 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.53e-05 | 197 | 150 | 6 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.53e-05 | 197 | 150 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 5.53e-05 | 197 | 150 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | COVID-19_Severe-B_naive|COVID-19_Severe / disease group, cell group and cell class | 5.53e-05 | 197 | 150 | 6 | b8f18b39435e2229ba3bc07a25eb875d1ec11f6f | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.69e-05 | 198 | 150 | 6 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 5.69e-05 | 198 | 150 | 6 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.69e-05 | 198 | 150 | 6 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.69e-05 | 198 | 150 | 6 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.69e-05 | 198 | 150 | 6 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.85e-05 | 199 | 150 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-B-B_memory|ICU-NoSEP / Disease, condition lineage and cell class | 5.85e-05 | 199 | 150 | 6 | acd2b87ab0d7d92515cf46ab65b766d6ade818a6 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-B-B_memory|COVID-19_Convalescent / Disease, condition lineage and cell class | 5.85e-05 | 199 | 150 | 6 | 5bbda86486910d053ca51b9caee487d78f6462cb | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.02e-05 | 200 | 150 | 6 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | severe-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.02e-05 | 200 | 150 | 6 | 0e86f52b6e146d9bbc728d8fb176fc2b53696558 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.02e-05 | 200 | 150 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | mild-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.02e-05 | 200 | 150 | 6 | 222789b897e2a683bbfd1d00b6fd8705015d90df | |
| ToppCell | severe-B_naive|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.02e-05 | 200 | 150 | 6 | 306df1f498ac2188eaf9f2a8d002bb73bdb9642d | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.43e-05 | 135 | 150 | 5 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.20e-04 | 142 | 150 | 5 | f720f13b339589fa924a42e89393e5db0b26300b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col18a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-04 | 148 | 150 | 5 | fc80c02b51cf55a04ce550838ee2f41d8f656f41 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_ALM_Trhr_Nefl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.50e-04 | 149 | 150 | 5 | 558a441804dbcd5b5f39a3b1933b48976711ff15 | |
| ToppCell | COVID-19_Severe-B_cell|World / disease group, cell group and cell class | 1.50e-04 | 149 | 150 | 5 | 9a9fcbf7e8a6811958f3fd2d36315e19ab2b1127 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.55e-04 | 150 | 150 | 5 | 2ba55e51877e2e749cccdae7df5d885dc55b2587 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.55e-04 | 150 | 150 | 5 | d9931507257c64ead4a53786e6822f51962c6015 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.59e-04 | 151 | 150 | 5 | 0f8f07e44c6edaf09574930b416fdce14d67095a | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-Naive_B_cells|Lung / Manually curated celltypes from each tissue | 1.75e-04 | 154 | 150 | 5 | 2b7d7f09c75bbc22de1358fc44b8ad5d3f656617 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-04 | 155 | 150 | 5 | 77ae0b8d30bc3db4a73fd5340f99691a73d2684f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.86e-04 | 156 | 150 | 5 | 09e0702400570089d9012dcf94dfb4827c97e49d | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 156 | 150 | 5 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.15e-04 | 161 | 150 | 5 | e3327c296d48e821004e61a573abb75624a6f040 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.92e-05 | 50 | 87 | 5 | GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.92e-05 | 50 | 87 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Disease | nervousness | 6.34e-05 | 16 | 146 | 3 | NCIT_C74532 | |
| Disease | Behcet Syndrome | 2.23e-04 | 24 | 146 | 3 | C0004943 | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 2.41e-04 | 5 | 146 | 2 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | REM sleep behavior disorder | 3.60e-04 | 6 | 146 | 2 | EFO_0007462 | |
| Disease | Alzheimer's disease (is_implicated_in) | 5.17e-04 | 132 | 146 | 5 | DOID:10652 (is_implicated_in) | |
| Disease | coffee consumption | 5.30e-04 | 32 | 146 | 3 | EFO_0004330 | |
| Disease | Major depression, single episode | 8.56e-04 | 9 | 146 | 2 | C0024517 | |
| Disease | airway imaging measurement | 8.82e-04 | 38 | 146 | 3 | EFO_0007627 | |
| Disease | Prostatic Neoplasms | 1.02e-03 | 616 | 146 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.02e-03 | 616 | 146 | 10 | C0376358 | |
| Disease | alpha wave measurement, electroencephalogram measurement | 1.07e-03 | 10 | 146 | 2 | EFO_0004357, EFO_0006870 | |
| Disease | bitter beverage consumption measurement | 1.18e-03 | 42 | 146 | 3 | EFO_0010089 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.78e-03 | 447 | 146 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | toxic shock syndrome (is_implicated_in) | 1.83e-03 | 13 | 146 | 2 | DOID:14115 (is_implicated_in) | |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 1.83e-03 | 13 | 146 | 2 | C0238288 | |
| Disease | fetal genotype effect measurement, body weights and measures | 1.85e-03 | 49 | 146 | 3 | EFO_0004324, EFO_0007959 | |
| Disease | thalamus volume change measurement | 2.13e-03 | 14 | 146 | 2 | EFO_0021496 | |
| Disease | non-alcoholic fatty liver disease, type 2 diabetes mellitus | 2.21e-03 | 110 | 146 | 4 | EFO_0003095, MONDO_0005148 | |
| Disease | coffee consumption, cups of coffee per day measurement | 2.79e-03 | 16 | 146 | 2 | EFO_0004330, EFO_0006782 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 2.79e-03 | 16 | 146 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | body fat percentage | 3.06e-03 | 488 | 146 | 8 | EFO_0007800 | |
| Disease | major depressive disorder (is_implicated_in) | 3.15e-03 | 17 | 146 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | Feeding difficulties | 3.53e-03 | 18 | 146 | 2 | C0232466 | |
| Disease | respiratory syncytial virus infectious disease (is_marker_for) | 3.53e-03 | 18 | 146 | 2 | DOID:1273 (is_marker_for) | |
| Disease | non-word reading | 4.51e-03 | 67 | 146 | 3 | EFO_0005299 | |
| Disease | Ovarian Failure, Premature | 4.80e-03 | 21 | 146 | 2 | C0085215 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FQDSKNSDLYSIMKN | 531 | P35869 | |
| KMSSLSILFFDENKN | 441 | P12645 | |
| NIKSDVFMTQFSALQ | 2406 | Q9NR48 | |
| FFQTENEIASKAMLS | 61 | Q9H7T0 | |
| FLNLTKESQKNSAMS | 1661 | Q86UK0 | |
| AATMSNKFTQKGNFR | 866 | Q14833 | |
| KDQASFLSDSNMFIN | 3251 | Q86UQ4 | |
| NSIFLSNLMKSANTF | 6 | Q13489 | |
| IFKNTSFIKGMFNSA | 1036 | Q14692 | |
| SSQKDKVRQFMIFTQ | 6 | Q96GG9 | |
| KEKFRTMESNQKSSF | 106 | O75071 | |
| DKFTDSAIAMNSKVN | 206 | Q8WWM7 | |
| DNSFNQELLKSMVKS | 1756 | Q7Z401 | |
| MQAFFTVKQKSIANG | 251 | Q8NFF2 | |
| KQAFINMARKTVFFT | 296 | Q96RD1 | |
| ESSFNKKNMFQVIHT | 666 | Q15283 | |
| NFVTNIKRKDFANMT | 61 | Q96NI6 | |
| FNEQNFVSKSDIKSM | 101 | Q9NWU1 | |
| SVAAQISNNMTEKKF | 846 | Q9H2M9 | |
| FVKNMNRDSTFIVNK | 446 | P32926 | |
| SLRNKQVIASFTKMF | 291 | A6NHG9 | |
| AVTVMFDKVQFSNKS | 196 | Q9NZL9 | |
| FDKVQFSNKSANMDH | 201 | Q9NZL9 | |
| KAFSENMLDQSAITK | 1196 | Q8IV33 | |
| DAFSRVKTFFQMKDQ | 46 | P22301 | |
| VANMAFSNDLFNKSS | 581 | Q17R60 | |
| QVQKFISMAFSPDSK | 106 | Q96MR6 | |
| NMQSSSLKLFSSFEQ | 2011 | Q9Y3R5 | |
| NSFTKFGNRNVFMKD | 396 | Q96PV6 | |
| MADLNFKISKNETST | 721 | Q5U5R9 | |
| LKMFSDKSESNTINF | 3046 | Q5CZC0 | |
| FSNNNESAAKMIKET | 46 | O96015 | |
| KEKAKQLNSDMNFFN | 101 | Q8N140 | |
| VSAKNALESYAFNMK | 536 | P0DMV9 | |
| NDLKSVNFDMTSKFL | 571 | Q8WUM4 | |
| VNFDMTSKFLTALAQ | 576 | Q8WUM4 | |
| SFQNNSKVVAFMKSP | 26 | Q96B96 | |
| SAFSKTDENNFKMFA | 391 | Q9Y233 | |
| QTSLAQFLKLFDQSM | 3706 | Q96JB1 | |
| VDMSSFNAFESKQQS | 821 | Q6ZNL6 | |
| LSEKSSGQMAQKFSF | 101 | Q96Q89 | |
| NEFQNLKSHMENTFK | 781 | Q96Q89 | |
| LKFANDKSMSGNKFQ | 2511 | Q6ZR08 | |
| MKKEVNFSVDQNTSS | 221 | Q8NG31 | |
| NKTVFKSKQNTAFQD | 386 | Q8NG31 | |
| ESQKAMVAFFNSAVA | 21 | Q9HBQ8 | |
| FRSFKDSATKQKLMN | 601 | Q9BSC4 | |
| ETQRTFKGNAQKMFS | 166 | Q9H8H2 | |
| FFQALNHAEQTFKKM | 196 | Q96PQ7 | |
| SSQKKMAAELQFQFV | 3031 | O95613 | |
| VGFSKFTFTRMKNSQ | 816 | Q9NY74 | |
| LQESKSKFQREMSNS | 1311 | A2PYH4 | |
| SEKNFQLNQDKMNFS | 51 | Q9Y244 | |
| MSAFVKASAFALQEQ | 281 | P36957 | |
| KTISKLMFDFQRNST | 11 | Q7Z3G6 | |
| FIQFTKKMESSDVNK | 186 | O95876 | |
| QSQTFSQVQMFLKDS | 546 | Q9P2D7 | |
| MNSSYVKFLKQATDN | 366 | P46100 | |
| MQDDLNFKSTEVQKS | 421 | Q96LB3 | |
| NFAMKEFIATKSQES | 556 | Q96LB3 | |
| KQFLSQFEMQSRKTT | 161 | Q16630 | |
| FFQQMIDSQNSKETK | 271 | Q9HB55 | |
| SIFNMANKKNTATQE | 521 | Q14CM0 | |
| MKEFTFLMENASKNQ | 436 | Q8TF40 | |
| KAFSEKRTSQSVNML | 461 | Q9P278 | |
| TMFVTASKDNTAKLF | 201 | Q13347 | |
| SAETTTLFQFNEMKK | 2626 | P12111 | |
| FKNSENSSFLPMKNE | 796 | Q5U5Z8 | |
| FSFSPANMVSAVKQK | 541 | Q9UH73 | |
| NFSTNVTAAKTKEMI | 1891 | Q0VDD8 | |
| TSMAFKNIASKIANE | 771 | Q7KZI7 | |
| KAEMTLKTNFFATRN | 106 | O75828 | |
| HSKASASFSEQKNLM | 536 | Q6UWL6 | |
| EAFSFDLQKAQSKME | 706 | Q9ULL0 | |
| VNMLFNKSLFSTNKK | 171 | Q9NYL5 | |
| LDNQMKHSFDSASNK | 496 | Q5FWF5 | |
| ATEAFFAMTKLFQSN | 66 | Q9Y678 | |
| VSAKNALESYAFNMK | 536 | P0DMV8 | |
| SKTDLFQFNASMQQE | 3331 | Q8NDH2 | |
| AENNNSIMSFFKTLV | 281 | O75363 | |
| EKKLSASQMAAFQDA | 41 | Q8N7B9 | |
| KVKQQFMTTQDASKD | 61 | O76038 | |
| MNPFQKNESKETLFS | 1 | Q16348 | |
| AQGKNFLMSKFSSLN | 771 | Q9Y2H2 | |
| FLMSKFSSLNQKVKQ | 776 | Q9Y2H2 | |
| QSVVLSKMNFESFVK | 76 | P43246 | |
| LQEKNTESSENMTKF | 511 | Q68DL7 | |
| SVKTSQALKNPMFFF | 46 | Q8NGL9 | |
| FNFSKSNVMDVKDRS | 201 | Q93086 | |
| MNSSHDKKQAQALAF | 51 | Q8TBY8 | |
| KTNQMLEAFEQKDFS | 226 | Q9BXD5 | |
| NTLTLKDNAFNMSDK | 451 | Q8NHP6 | |
| MAHFSKKFDALQNEN | 261 | Q5TD94 | |
| NTTKKYNIMAFNAAD | 21 | P35269 | |
| NTTDNFFKISNLKMG | 2076 | Q92673 | |
| DFTFQNMNSKRKAET | 256 | Q15208 | |
| FLTESLKQFTEKMQS | 286 | P14373 | |
| QMTFETSFQFLKQAT | 1671 | O95602 | |
| NDKFQVSTNKLTFMD | 516 | A6NHR9 | |
| SDFSFQNMNSKRKAE | 256 | Q9Y2H1 | |
| KAQSSQDAVSSMNLF | 276 | Q9UHX1 | |
| KKFNSSVLSFEIKNM | 76 | Q96CG3 | |
| KGNFSSFMQKEIFEQ | 336 | Q06210 | |
| NKQQFVNLKEMFSNS | 31 | Q3BBV2 | |
| FKFMSNTVFRKNSSL | 436 | O60331 | |
| VSVESKMNNKAGSFF | 11 | Q9NYY8 | |
| SFMNTELAAFTKNQK | 41 | P31949 | |
| DVMKKLSNTSYQFAA | 181 | P20701 | |
| NLMKKAASITSEVFN | 181 | Q9Y5B9 | |
| FEDNFSSMNLDKKIN | 151 | Q01968 | |
| ADNKFNSITMNFKEA | 331 | Q8TDI8 | |
| ASNRFKTLMTNKSEQ | 866 | Q8N961 | |
| KANSFTAQLNMFASV | 111 | P46091 | |
| DVFSKRNSSNKMVVS | 396 | Q96KN2 | |
| SQKRSAVEKSMNTFL | 276 | Q9Y2G3 | |
| KEQKNLNSFFAVMFG | 746 | O95398 | |
| MSRKQNQKDSSGFIF | 1 | Q86XZ4 | |
| MSASLNYKSFSKEQQ | 1 | Q9BYV6 | |
| NYKSFSKEQQTMDNL | 6 | Q9BYV6 | |
| FDLRNTSQKMFVNTK | 211 | Q9NXC5 | |
| FDFTAKGAMSTQQIK | 636 | P49588 | |
| VSSKEVNKFQMAYSN | 71 | P37108 | |
| FNAVKAAKSDMQSLV | 101 | Q9UJ98 | |
| KQLMTNLSHKDVNFS | 131 | Q5EBL4 | |
| LMNAIFSKKNFESLS | 236 | P04844 | |
| TFFNKVIANESKNRM | 516 | Q9P2N2 | |
| AQKSLSEYNNFKSMV | 756 | P24928 | |
| NMKKAFKSSTVQDQQ | 96 | Q9UPY6 | |
| NTSFSRGFTKNMKLE | 401 | Q5VUG0 | |
| QLFMTDVKENFKTSL | 1696 | O60281 | |
| MTFDSAKSKLTRNNF | 166 | P45880 | |
| QISSNYDDAMQFSKK | 526 | Q9Y2X9 | |
| AMRANYKNNSKSLFN | 106 | Q9P0W8 | |
| VDLSNKINEMKTFNS | 1041 | Q9Y6N7 | |
| NMSSQFKDLKVNLSA | 531 | O43548 | |
| NTDLFKAESMFTNAV | 351 | O95427 | |
| SSDQKNAMLDFVFTV | 41 | Q96BW9 | |
| TNFIKIANLSMFKQF | 406 | Q9NYK1 | |
| RFKNKEASFMSVNES | 476 | Q9NYK1 | |
| SNQQKNFKMQSAAFS | 871 | P49750 | |
| NFKMQSAAFSIAADV | 876 | P49750 | |
| KFENMKSSLSNEVNE | 631 | Q9BZF9 | |
| LSQKNENEMFSTVFS | 431 | Q93050 | |
| MKISFNDKSLQTTFE | 576 | Q4KMQ1 | |
| QQKMNISQASVSFKD | 36 | Q9Y2H8 | |
| FKKFEKNNLFQMSNS | 291 | Q6NXT6 | |
| SMKEVNKALSNQFIS | 131 | Q8N6G2 | |
| SDKANMLQEYSKFLQ | 596 | Q9UQR1 | |
| QEKMASFSFLKDNST | 2106 | Q9BXT5 | |
| VEKINEKFSNFFSSM | 936 | Q8IY18 | |
| SQYFKAQTEARKQMS | 306 | P11387 | |
| MDTFSTKSLALQAQK | 1 | Q8WVP5 | |
| KSFNLNKSKEETDFM | 11 | O14544 | |
| GFKITQNNAMKISFA | 266 | P09012 | |
| MSFTANSSKIDRQKV | 511 | P35125 | |
| MSHSAFFNKKTLNTE | 156 | Q9Y473 | |
| FMFTEKTLQSINNAF | 121 | A8MPX8 | |
| VVQAKKFSNVTMLFS | 471 | Q02108 | |
| KAQLDSFVKSMSSLQ | 2456 | Q14789 |